Q-Line Biotech Ltd.

NSE: QLINE

QLine Biotech Live Share Price Today, Share Analysis and Chart

Name: Q-Line Biotech Ltd.: Is Infosys Ltd. worth buying?
Item: Q-Line Biotech Ltd.
Rating: 1.0395
Author: Trendlyne DVM scores

aboutQ-Line Biotech was incorporated on November 10, 2010. The company develops, manufactures, and markets diagnostic reagents, kits, consumables, and point-of-care devices, while also supplying diagnostic and pathology equipment for healthcare providers.... Read More

18.85(3.75%)

57,000

NSE Volume

NSE 03 Nov, 2026 3:31 PM (IST)

Portfolio

Alert

My Notes

- / 100

17.6 / 100

No estimates available

SWOT Analysis

Check Before You Buy

VIEW FULL CHECKLIST

Medium rank

5Positive8Negative

38.5%Pass in checklist

045

100

Check P/E Buy Sell Zone

Strong Sell Zone

100.0 % into P/E buy sell zone

% time spent below current P/E

020406080100

Strong upside potential

Gains already realized

QLine Biotech Stock Price Analysis

Day Price Range 3.8% 1 Day return	521.8 (LTP) 507539.9 LowHigh
Week Price Range -3.6% 1 Week return	521.8 (LTP) 495574 LowHigh
Month Price Range -21.1% 1 Month return	521.8 (LTP) 495685.4 LowHigh
52 Week Price Range 52.1% 1 Year return	521.8 (LTP) 431735 LowHigh

View full Price History/Seasonality

Competitors/Peers

Revenue Mix

Annual

Balance Sheet

Ratios

Cash Flow

Documents

QLine Biotech annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Annual Revenue QLine Biotech Mar-2026 Annual Revenue is Rs 347 Cr which is growth of 7.8% YoY.
POSITIVE
Annual Net Profit QLine Biotech Mar-2026 Annual Net Profit is Rs 57 Cr which is growth of 20.2% YoY.

Q-Line Biotech Ltd., Annual, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20
SR_A Total Rev. Ann. ⌄	23.2%	15.9%	346.9	321.9	206.5	185.5	279.8	166.2	86.3
TotalOperatingRevenues_A Operating Rev. Ann.	23.1%	15.5%	341.2	313.1	203.7	183.1	278.4	165.7	85.1
OI_A Other Income Ann.	33.4%	70.1%	5.7	8.8	2.8	2.4	1.4	0.4	1.3
OEXPNS_A Operating Exp. Ann.	18.2%	11%	242	241.5	160.3	146.6	211.7	143.9	70.1
OEXPNS_A Operating Exp. Ann.	18.2%	11%	242	241.5	160.3	146.6	211.7	143.9	70.1
OP_A Operating Profit Ann.	39.5%	35.4%	99.1	71.5	43.3	36.5	66.6	21.8	14.9
OPMPCT_A OPM Ann. %	13.3%	16.8%	28.57%	22.22%	20.99%	19.66%	23.82%	13.13%	17.28%
TotalExpenses_A Total Exp. Ann. ⌄	21.1%	13%	271.7	263.4	171.7	152.9	216	147.3	71.9
OtherExpenses_A Other Exp. Ann.	32.5%	34.5%	69.1	65.4	35.1	29.7	37	15.7	11.5
EmployeeBenefitExpenses_A Employee Exp. Ann.	19.2%	13.4%	38.8	29.9	24	22.9	24.1	20.7	16.8
CostOfPowerPurchased_A Cost Of Power Purchased Ann.	-	-
CostOfFuel_A Cost Of Fuel Ann.	-	-
EBIDT_A EBITDA Ann.	39.3%	36.3%	104.9	80.4	46.2	38.8	68	22.3	16.2
EBIDTPCT_A EBITDA Ann. margin %	13%	17.7%	30.23%	24.97%	22.36%	20.94%	24.31%	13.39%	18.74%
INT_A Interest Ann.	61.3%	51.1%	18.9	14.9	7.1	4.5	3	2.4	0.9
DEP_A Depr.	81.7%	64.4%	10.8	6.9	4.2	1.8	1.3	0.9	0.9
PBT_A PBT Ann.	32.1%	31.8%	75.2	58.5	34.9	32.6	63.7	18.9	14.4
TAX_A Tax Ann.	27.2%	28.7%	17.3	19.2	9	8.4	16.2	4.9	4.2
PAT_A PAT Before ExtraOrdinary Items Ann. ⌄	33.7%	32.8%	57.9	39.4	25.9	24.2	47.5	14	10.2
IncomeMinorityInterest_A Minority Interest Income Ann.	-	-	-	-	-	-	-	-	-
NP_A Net Profit Ann.	33.1%	32.4%	57	47.4	25.9	24.2	47.5	14	10.2
NETPCT_A NPM Ann. %	8.1%	14.6%	16.69%	15.13%	12.69%	13.20%	17.06%	8.46%	11.96%
EPS_adj_A EPS Adj. latest Ann.	32.9%	32.4%	24.4	20.3	11.1	10.4	20.4	6	4.4

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

VIEW ALL TABLE IN FINANCIAL PAGE

Total Rev. Ann.

1Y CHG

7.8%

2Y CAGR

29.6%

3Y CAGR

23.2%

5Y CAGR

15.9%

Net Profit Ann.

1Y CHG

20.3%

2Y CAGR

48.3%

3Y CAGR

33.1%

5Y CAGR

32.4%

Operating Exp. Ann.

1Y CHG

0.2%

2Y CAGR

22.9%

3Y CAGR

18.2%

5Y CAGR

11%

QLine Biotech Technical Analysis

QLine Biotech EMA & SMA

Bearish-7

0 bullish, 7 bearish

Bullish0

Bearish7

5 Day	524.1
10 Day	541.8
12 Day	548.8
20 Day	571.3

26 Day	581.7
50 Day	592.3
100 Day	565.4

QLine Biotech Delivery And Volume

Daily Avg. Delivery Volume %

03 Nov, 202664.6%

Week67.3%

Month63.1%

Legend

Positive IndicatorNeutral IndicatorNegative Indicator

QLine Biotech Resistance and Support

522.92

Pivot

First Resistance	538.8
Second Resistance	555.8
Third Resistance	571.7

First Support	505.9
Second Support	490.0
Third Support	473.0

Day RSI	35.6
Day MACD	-32.8
Day MFI	38.7
Day MACD Signal Line	-24.8

QLine Biotech Beta

1 Month	0.9
1 Year	-

3 Month	0.7
3 Year	-

QLine Biotech Price Change Analysis

↓-21.1%

Over 1 Month

LowHigh

495685.4

↓-3.6%

Over 3 Months

LowHigh

495735

↑52.1%

Over 6 Months

LowHigh

431735

↑52.1%

Over 1 Year

LowHigh

431735

QLine Biotech Shareholding Pattern/ Ownership

Shareholding Summary

Sep 2026

Name	Category	Shares	Shares %
Saurabh Garg	Promoter	10,191,000	43.7 %
Llp	Public	300,100	1.3 %
Abakkus Small Cap Fund	Dii	513,600	2.2 %

HISTORICAL PROMOTER HOLDING

HISTORICAL FII HOLDING

HISTORICAL MF HOLDING

All Shareholding details

QLine Biotech Deals - Insider, Bulk, Block and SAST

Client Name	Deal Type	Action	Date	Avg. Price	Quantity	Exchange
F3 ADVISORS PRIVATE LIMITED	Bulk	Sell	29 May 2026	451	400	NSE
EXCELLENT SHARES AND FINANCE SERVICES PRIVATE LIMITED	Bulk	Purchase	29 May 2026	452	150,000	NSE
AFFLUENCE GEMS PRIVATELIMITED	Bulk	Purchase	29 May 2026	452	150,000	NSE
F3 ADVISORS PRIVATE LIMITED	Bulk	Purchase	29 May 2026	454.03	123,600	NSE
MANSI SHARE AND STOCK BROKING PRIVATE LIMITED	Bulk	Purchase	29 May 2026	448.47	136,400	NSE
SETU SECURITIES PVT LTD	Bulk	Purchase	29 May 2026	444.27	244,400	NSE

All deals

QLine Biotech Corporate Actions

QLine Biotech Board Meetings

QLine Biotech past and upcoming board meetings.

#Ex-Date	Purpose	Notes
105 Sep 2026	Other business matters	-
217 Jun 2026	Audited Results & Others	Inter-alia, to consider 1. Approve the Internal Audit Report of the Company. 2. Other business matters.

All Corporate Actions

QLine Biotech - Company Profile

QLine Biotech Board of Directors

QLine Biotech Board of directors with salaries, total experience, and qualifications.

NAME	POSITION	GROSS REMUNERATION ₹(LAC)	AS OF
Ajay Kumar Mahanty	Whole-time Director	97.57	Mar 25
Kuldeep Chowdhry	Whole Time Director	63.18	Mar 25
Akhand Pratap Singh.	Company Secretary / Compliance Officer	0.9	Mar 25
Saurabh Garg	Chairman & Managing Director	0.14	Mar 25
Yethadka Subraya Prabhakara	Whole-time Director	-	Mar 25
Abhay Agrawal	Non Executive Director	-	Mar 25
Amita Garg	Non Executive Director	-	Mar 25
Ayush Garg	Non Executive Director	-	Mar 25
Abhishek Mishra	Independent Director	-	Mar 25
Pravir Kumar	Independent Director	-	Mar 25
ROHIT NANDAN	Independent Director	-	Mar 25
Jai Prakash Singh	Independent Director	-	Mar 25

About

Website: www.qlinebiotech.com

About the company - Business Profile

Q-Line Biotech was incorporated on November 10, 2010. The company develops, manufactures, and markets diagnostic reagents, kits, consumables, and point-of-care devices, while also supplying diagnostic and pathology equipment for healthcare providers. Its operations span clinical chemistry, haematology, immunodiagnostics, molecular diagnostics, and rapid testing solutions

QLine Biotech FAQ

QLine Biotech today is trading in the green, up by 3.75% at ₹521.85.

QLine Biotech is currently trading up 3.75% on an intraday basis. In the past week the stock fell 3.65%. Stock has been down 3.59% in the past quarter and rose 52.14% in the past year. You can view this in the share price history/seasonality section.

QLine Biotech is listed on NSE with the ticker QLINE. It's currently trading on NSE at a share price of ₹521.85.

The market cap of QLine Biotech is ₹1,217.38 Cr. as of Nov 03, 2026.

QLine Biotech has never announced any dividend since the time of its listing on the NSE exchange.

QLine Biotech has never issued stock splits or bonus shares since the time of its listing on the NSE exchange.

QLine Biotech reported ₹347.44 Cr. in revenue, ₹55.72 Cr. in net profit, and ₹103.75 Cr. in EBITD as of Mar 31, 2026 for FY25-26.

There are no analyst predictions for stock price target for QLine Biotech.

The PE ratio of QLine Biotech is 21.85 as of Nov 03, 2026.

The PB ratio of QLine Biotech is 5.15 as of Nov 03, 2026.

There are no analyst reports for QLine Biotech.

You can set real-time stock alerts on price, volume, SMA, and several other parameters by scrolling to the top of this page and clicking the bell icon on the far right-hand side of the stock overview.

Key Metrics
DVM
Price Chart
Forecaster
Financials
Technicals
Shareholding
Deals
Documents
Corporate actions
Company Profile

QLine Biotech Live Share Price Today, Share Analysis and Chart

SWOT Analysis

Check Before You Buy

Check P/E Buy Sell Zone

QLine Biotech Stock Price Analysis

Day Price Range

Week Price Range

Month Price Range

52 Week Price Range

QLine Biotech - Annual

QLine Biotech annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history

Annual Revenue QLine Biotech Mar-2026 Annual Revenue is Rs 347 Cr which is growth of 7.8% YoY.

Annual Net Profit QLine Biotech Mar-2026 Annual Net Profit is Rs 57 Cr which is growth of 20.2% YoY.

QLine Biotech Technical Analysis

QLine Biotech EMA & SMA

QLine Biotech Delivery And Volume

QLine Biotech Resistance and Support

QLine Biotech Beta

QLine Biotech Price Change Analysis

QLine Biotech Shareholding Pattern/ Ownership

Shareholding Summary

HISTORICAL PROMOTER HOLDING

HISTORICAL FII HOLDING

HISTORICAL MF HOLDING

QLine Biotech Deals - Insider, Bulk, Block and SAST

Bulk Block Deals

QLine Biotech Corporate Actions

QLine Biotech Board Meetings

QLine Biotech past and upcoming board meetings.

QLine Biotech - Company Profile

QLine Biotech Board of Directors

QLine Biotech Board of directors with salaries, total experience, and qualifications.

About the company - Business Profile

QLine Biotech FAQ

How is QLine Biotech today?

QLine Biotech today is trading in the green, up by 3.75% at ₹521.85.

How has QLine Biotech performed historically?

QLine Biotech is currently trading up 3.75% on an intraday basis. In the past week the stock fell 3.65%. Stock has been down 3.59% in the past quarter and rose 52.14% in the past year. You can view this in the share price history/seasonality section.

What is the current share price of QLine Biotech on NSE and BSE exchanges?

QLine Biotech is listed on NSE with the ticker QLINE. It's currently trading on NSE at a share price of ₹521.85.

What is the market cap of QLine Biotech?

The market cap of QLine Biotech is ₹1,217.38 Cr. as of Nov 03, 2026.

When did QLine Biotech last pay a dividend, and what has its dividend history been?

QLine Biotech has never announced any dividend since the time of its listing on the NSE exchange.

Has QLine Biotech issued any bonus shares or share splits recently?

QLine Biotech has never issued stock splits or bonus shares since the time of its listing on the NSE exchange.

What do the financial statements and annual reports of QLine Biotech Indicate?

QLine Biotech reported ₹347.44 Cr. in revenue, ₹55.72 Cr. in net profit, and ₹103.75 Cr. in EBITD as of Mar 31, 2026 for FY25-26.

What is the target share price of QLine Biotech according to analyst predictions in FY26-27?

There are no analyst predictions for stock price target for QLine Biotech.

What is the PE Ratio of QLine Biotech?

The PE ratio of QLine Biotech is 21.85 as of Nov 03, 2026.

What is the PB Ratio of QLine Biotech?

The PB ratio of QLine Biotech is 5.15 as of Nov 03, 2026.

Where can I check the latest Research Reports about QLine Biotech?

There are no analyst reports for QLine Biotech.

How can I be notified of real time alerts about QLine Biotech stock?

You can set real-time stock alerts on price, volume, SMA, and several other parameters by scrolling to the top of this page and clicking the bell icon on the far right-hand side of the stock overview.